Kevin Xu Joins Global Leaders at Africa Gate to Growth Forum 2025
Global Business Leaders Convene at Berkeley for West African Economic Growth
The Africa Gate to Growth Forum 2025 took place on February 21 at the Haas School of Business, University of California, Berkeley, uniting top industry leaders, policymakers, and innovators to discuss the future of economic development in West Africa.
MEBO Group’s Role in Advancing International Collaboration
Kevin Xu, Chairman of MEBO Group, was a key participant at the forum, engaging in high-level discussions with H.E. Inza Camara, Special Envoy for the Economic Promotion Service (SPECI) of Côte d'Ivoire. Their conversation centered on fostering strategic partnerships, accelerating sustainable growth, and enhancing economic ties between West Africa and North America.
Côte d'Ivoire’s Rising Investment and Economic Strategy
Spearheading Côte d'Ivoire’s global economic expansion, Special Envoy Camara has been instrumental in strengthening trade and investment between North America and Côte d'Ivoire. In 2024 alone, direct investments from North American businesses in Côte d'Ivoire soared to $2.7 billion, reflecting the country’s growing economic potential.
Strengthening International Cooperation for Sustainable Development
Themed “Dialogue, Innovation, and Collaboration in West African Finance and Technology,” the forum was hosted by Côte d'Ivoire’s Ministry of Digital Transformation, SPECI, and the Africa Business Club at Berkeley Haas. With MEBO Group’s strong foundation in international medical technology and sustainable industries, the company’s vision aligns with Côte d'Ivoire’s key development priorities, reinforcing global collaboration for long-term economic growth.
About MEBO
Founded in 1987 by Professor Rongxiang Xu, a distinguished Chinese life scientist, MEBO Group is a multinational headquartered in both China and the USA. It integrates research, development, and sales across the pharmaceuticals, medical devices, health foods, and cosmetics sectors.
At its core, MEBO focuses on regenerative life sciences, innovating with over 100 patents and more than ten joint research bases to enhance and enable the body's own regenerative abilities.
As a leader in regenerative life science, MEBO's extensive research facilities and products impact over 100 countries globally, pioneering new frontiers in the regenerative life world.